:: Library Catalog

Copertina

Salvato in:

Dettagli Bibliografici
Autore principale:	Mamoor, Shahan
Natura:	Recurso digital
Lingua:
Pubblicazione:	Zenodo 2025
Accesso online:	https://doi.org/10.5281/zenodo.17748343
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

ABCA12 functions in multi-drug resistance in human cancer.
di: Mamoor, Shahan
Pubblicazione: (2025)

ABCG2 functions in multi-drug resistance in human cancer in metastasis to the bone.
di: Mamoor, Shahan
Pubblicazione: (2025)

Exploring the Causal Relationship Between the Plasma Levels of MMP1 (Matrix Metalloproteinase‐1), MMP3, MMP7, MMP10, and MMP12 and Intervertebral Disc Degeneration: Mendelian Randomization
di: Lin Sun, et al.
Pubblicazione: (2025)

Levels of matrix metalloproteinase‐1 ( MMP ‐1), MMP ‐2, MMP ‐3, osteopontin, pentraxin‐3, and thymic stromal lymphopoietin in crevicular fluid samples from peri‐implantitis, periodontitis, and healthy sites
di: Leif Jansson, et al.
Pubblicazione: (2024)

An expression screen to identify genes important for trastuzumab resistance: Pax8-as1.
di: Mamoor, Shahan
Pubblicazione: (2026)

Ribosomal activation in TNBC resistance in vitro.
di: Mamoor, Shahan
Pubblicazione: (2025)

SLX1B is active during transformation and controls relapse and resistance in human cancer.
di: Mamoor, Shahan
Pubblicazione: (2025)

Xist is activated during resistance in triple negative breast cancer in vitro.
di: Mamoor, Shahan
Pubblicazione: (2025)

Glucocorticoid resistance features changes in general transcription factor (GTF) expression.
di: Mamoor, Shahan
Pubblicazione: (2025)

An expression screen to identify genes important for trastuzumab resistance: Ccl19.
di: Mamoor, Shahan
Pubblicazione: (2026)

An expression screen to identify genes important for trastuzumab resistance: Meox2.
di: Mamoor, Shahan
Pubblicazione: (2026)

Exploring Flavonoids as Regulators of MMP‐2 and MMP‐9 in Cancer Pathogenesis
di: Ha Vy Thi Vo, et al.
Pubblicazione: (2025)

Membrane‐type I metalloproteinase ( MT1 ‐ MMP ): A key modifier of extracellular matrix microenvironment
di: Yoshifumi Itoh, et al.
Pubblicazione: (2026)

ABC transporter multi-drug resistance genes ("pumps") in humans with non-small cell lung cancer.
di: Mamoor, Shahan
Pubblicazione: (2025)

Therapeutic targeting in breast cancer for the treatment of lung metastasis: PPP1R9A.
di: Mamoor, Shahan
Pubblicazione: (2025)

Therapeutic targeting in breast cancer for the treatment of lung metastasis: PPP1R9A.
di: Mamoor, Shahan
Pubblicazione: (2025)

FCGRT functions in senescence and transformation.
di: Mamoor, Shahan
Pubblicazione: (2025)

Association of MMP‐2 and MMP‐9 Polymorphisms and the Pathogenesis of Childhood Burkitt's Lymphoma
di: Elienay Ferreira da Silva, et al.
Pubblicazione: (2026)

Oral Mucositis in Oncopediatric Patients: MTX and MMP ‐1, MMP ‐8, MMP ‐13 Gene Polymorphisms
di: Nicole Januário Ribeiro, et al.
Pubblicazione: (2026)

Androgen signaling has functions in lineage commitment in the human embryo.
di: Mamoor, Shahan
Pubblicazione: (2026)

H7N9 PA-X silences Ifi6.
di: Mamoor, Shahan
Pubblicazione: (2026)

Genes that function in axon guidance are associated with disease progression in breast and lung cancer.
di: Mamoor, Shahan
Pubblicazione: (2025)

Therapeutic targeting in breast cancer for the treatment of lymph node metastasis: MYO9B.
di: Mamoor, Shahan
Pubblicazione: (2025)

Haglr, a HOXD antisense growth-associated long non-coding RNA with functions in lineage commitment in the human embryo.
di: Mamoor, Shahan
Pubblicazione: (2026)

Increased matrix metalloproteinase‐2 in ligamentum flavum hypertrophy and the regulation of MMP‐2/TIMPs by elastin‐derived peptides
di: Wen‐Hai Zhuo, et al.
Pubblicazione: (2024)

MAP3K6 functions in compensatory feedback signaling during clinical interventions featuring use of the VEGF-A inhibitor bevacizumab.
di: Mamoor, Shahan
Pubblicazione: (2025)

Vitamins as potent cancer treatments through regulating the activity and expression of MMP ‐2 and MMP ‐9
di: Yen Thi Nguyen, et al.
Pubblicazione: (2026)

6-Gingerol inhibits hair cycle via induction of MMP2 and MMP9 expression
di: CHUN HOU
Pubblicazione: (2017)

The integral membrane protein SMIM38 is transcriptionally activated in circulating tumor cells in human breast cancer in conjunction with two SMIM38-interacting proteins of undefined function, ETDA and ETDB.
di: Mamoor, Shahan
Pubblicazione: (2025)

Effects of Melatonin on the Expression of Invasion‐Related Markers (MMP2 and MMP9) in Breast Cancer Cells
di: Parvin Ghadimi, et al.
Pubblicazione: (2025)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: SLC1A1.
di: Mamoor, Shahan
Pubblicazione: (2025)

Unbiased discovery of genes required for pluripotency: Terf1.
di: Mamoor, Shahan
Pubblicazione: (2026)

A comprehensive description of the circulating tumor cell: HCAR1.
di: Mamoor, Shahan
Pubblicazione: (2025)

Therapeutic targeting in colorectal cancer for the treatment of the primary tumor: BUB1.
di: Mamoor, Shahan
Pubblicazione: (2025)

Therapeutic targeting in breast cancer for the treatment of lung metastasis: ENOPH1.
di: Mamoor, Shahan
Pubblicazione: (2025)

Therapeutic targeting in breast cancer for the treatment of lung metastasis: MTFP1.
di: Mamoor, Shahan
Pubblicazione: (2025)

Therapeutic targeting in breast cancer for the treatment of liver metastasis: MINPP1.
di: Mamoor, Shahan
Pubblicazione: (2025)

Therapeutic targeting in breast cancer for the treatment of lung metastasis: PANK1.
di: Mamoor, Shahan
Pubblicazione: (2025)

Therapeutic targeting in breast cancer for the treatment of lung metastasis: FJX1.
di: Mamoor, Shahan
Pubblicazione: (2025)

Deletion of repeat B and C of Xist results in induction of SATB1.
di: Mamoor, Shahan
Pubblicazione: (2026)